when compared with bare-metal stents (BMSs), in patients undergoing percutaneous coronary intervention. Use of these stents rapidly became widespread in clinical practice. However, reports of ...

Clinical trials investigating the benefits of DES over bare-metal stents (BMS), however, have been insufficiently powered to generate useful data on rates of mortality, myocardial infarction (MI ...

Drug-eluting stents reduce the occurrence of in-stent restenosis and the need for subsequent target vessel revascularization when compared with bare-metal stents. However, drug-eluting stents may ...

Boston Scientific today shared study data supporting the use of its Eluvia drug-eluting stent for treating PAD.

Purpose: The mechanism of action and pharmacokinetics of sirolimus when used as part of a drug-eluting stent (DES) and the efficacy and cost of using DESs versus bare-metal stents are discussed.